Rossmax International (ROCO:4121) Forward PE Ratio: 0.00 (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4121 Rossmax International Ltd ROCO:4121
55 GF Score
Price NT$12.95
GF Value NT$18.19
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Rossmax International Forward PE Ratio?

Rossmax International ROCO:4121 -0.38% 55 Forward PE Ratio is 0.00 as of Aug. 17, 2026. GuruFocus rates ROCO:4121 with a GF Score™ of 55/100 and a GF Value™ of NT$18.19 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 390 Medical Devices & Instruments companies, Rossmax International ranks worse than 256410% on this metric.

Rossmax International's Forward PE Ratio for today is 0.00.

Rossmax International's PE Ratio without NRI for today is 0.00.

Rossmax International's PE Ratio (TTM) for today is 0.00.


Rossmax International  (ROCO:4121) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Rossmax International Forward PE Ratio Related Terms


Rossmax International Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Rossmax International's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossmax International Forward PE Ratio Chart

Rossmax International Annual Data
Trend
Forward PE Ratio

Rossmax International Quarterly Data
Forward PE Ratio

ROCO:4121 vs ABT, SYK, MDT: Forward PE Ratio Comparison

For the Medical Devices subindustry, Rossmax International's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rossmax International Forward PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rossmax International's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Rossmax International's Forward PE Ratio falls into.


ROCO:4121
55GF Score
Rossmax International Ltd ROCO:4121
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossmax International Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Rossmax International (ROCO:4121) has a Forward PE Ratio of 0.00 as of Aug. 17, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Rossmax International and its competitors. According to the industry distribution chart, Rossmax International ranks #999999 out of 390 companies in the Medical Devices & Instruments industry.
Is Rossmax International's Forward PE Ratio too high?
Rossmax International's current Forward PE Ratio is 0.00. Based on the distribution chart, Rossmax International ranks #999999 out of 390 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rossmax International has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's Forward PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rossmax International ranks #999999 out of 390 companies for Forward PE Ratio. This places Rossmax International in the lower half of its industry. The industry median Forward PE Ratio is 20.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 20.27, based on 390 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Rossmax International and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 20.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossmax International's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$18.19, compared to a current price of NT$12.95 — trading 28.8% below its estimated fair value. The current Forward PE Ratio is 0.00. Rossmax International's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current Forward PE Ratio is 0.00 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossmax International (ROCO:4121) Overvalued in 2026?

Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued. The current stock price of NT$12.95 is trading 28.8% below its estimated GF Value™ of NT$18.19. GuruFocus considers Rossmax International to be Modestly Undervalued.

Key valuation signals for ROCO:4121:

  • Forward PE Ratio: 0.00
  • GF Value™: NT$18.19 vs. price of NT$12.95 (28.8% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rossmax International Business Description

Address Kangchien Road, 12th Floor, No. 189, Neihu District, Taipei, TWN, 114
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
55GF Score

Get the complete analysis for ROCO:4121

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.95
Price
NT$18.19
GF Value